Prioritizing Comparative Effectiveness Research: Are Drug and Implementation Trials Equally Worth Funding?
Year of publication: |
2011
|
---|---|
Authors: | Gandjour, Afschin |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 29.2011, 7, p. 555-561
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Clinical-trial-design | Guideline-utilisation | Quality-of-care |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
National Performance Measures for Diabetes Mellitus Care: Implications for Health Care Providers
Akinci, Fevzi, (2004)
-
Koren, Michael J., (1998)
-
Perspectives on Dynamic Optimisation and Control Theory in Treating Hyperlipidaemia
Vernon, John A., (2007)
- More ...
-
Financial Incentives in the Path to Recovery from the COVID-19 Pandemic
Gandjour, Afschin, (2021)
-
Predictors of negotiated prices for new drugs in Germany
Gandjour, Afschin, (2020)
-
Shaikh, Mujaheed, (2018)
- More ...